A Modified 14-Day Dual Therapy with Vonoprazan and Amoxicillin Amplified the Advantages Over Conventional Therapies for Eradication of Helicobacter pylori: A Non-Inferiority Clinical Trial-Reference-Cited by-同舟云学术

A Modified 14-Day Dual Therapy with Vonoprazan and Amoxicillin Amplified the Advantages Over Conventional Therapies for Eradication of Helicobacter pylori: A Non-Inferiority Clinical Trial

Published:2023-08 Issue: Volume:Volume 16 Page:5637-5645
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Li Juan,Lv Lin,Zhu Yongjun,Zhou Zhihang,He Song

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference36 articles.

1. Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

2. Kyoto global consensus report onHelicobacter pylorigastritis

3. Global burden of cancers attributable to infections in 2012: a synthetic analysis

4. Helicobacter pyloritherapy: a paradigm shift

5. Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis;BMC Infectious Diseases;2024-09-11

2. Vonoprazan‐based therapies versus PPI‐based therapies in patients with H. pylori infection: Systematic review and meta‐analyses of randomized controlled trials;Helicobacter;2024-05

3. Vonoprazan-amoxicillin dual therapy with different amoxicillin dosages for treatment-naive patients of Helicobacter pylori infection in China: a prospective, randomized controlled study;European Journal of Gastroenterology & Hepatology;2024-03-19

4. Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy;Pharmacoepidemiology;2024-02-20

5. Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis;Helicobacter;2024-01